NL-OMON20374
Recruiting
Not Applicable
Evaluation of Optimized ROM and Shared Decision making: a cluster randomized trial
Stichting tot Steun VCVGZ0 sites336 target enrollmentTBD
ConditionsDepression, Anxiety disorders
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Depression, Anxiety disorders
- Sponsor
- Stichting tot Steun VCVGZ
- Enrollment
- 336
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Common mental disorder in ambulatory treatment
Exclusion Criteria
- •Severe mental Illnes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Shared Decision Making for choosing renAl Replacement Therapy in chronic kidney disease patientsDiseases of the genitourinary systemKCT0006452Seoul National University Bundang Hospital1,194
Not yet recruiting
Not Applicable
Effectiveness of Shared Decision Making with Decision Aids for Breast Cancer Patients Considering Breast Reconstruction: A Cluster Randomized Controlled Trialbreast cancerJPRN-UMIN000052161Jichi medical university of medicine120
Completed
Not Applicable
The OPTIMAAL study: Shared decision making between patients and GPs in the treatment of type 2 diabetes in primary care.adult onset diabetestype 2 diabetes mellitus10018424NL-OMON37364niversitair Medisch Centrum Utrecht250
Completed
Not Applicable
Efficacy of a combined shared decision-making intervention including a training program for oncologists and decision aids for breast and colon cancer patientsC50C18C19C20Malignant neoplasm of breastMalignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectumDRKS00000539niversitätsklinikum FreiburgPsychiatrie und PsychotherapieSektion Klinische Epidemiologie und Versorgungsforschung134
Not yet recruiting
Not Applicable
An evaluation and an examination of the optimization of the cancer immunotherapy for advanced non-small cell lung cancerPatients with advanced non-small cell lung cancer who are going to receive a therapy with immune checkpoint InhibitorsJPRN-UMIN000031127Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital20